A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.

Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...

ALS patients are living longer and more productive lives thanks to treatments and advances in research that increased understanding of the disease.

Reflecting on a scary road rage incident reminds columnist Kristin Neva of the fragility of life. None of us is guaranteed tomorrow.

A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...

Clene is continuing to work with U.S. regulators on its plans to seek accelerated approval of CNM-Au8 for the treatment of ...

Neurizon Therapeutics has entered into a global licensing deal with Elanco Animal Health to advance the development of NUZ-001 for ALS.

A coalition of ALS patients and caregivers is petitioning the FDA to review available data on the stem cell therapy NurOwn (debamestrocel).

Cannabis use by people with ALS can provide benefits such as pain relief, but may also interact with ALS medications and worsen symptoms.

ALS is a neurodegenerative condition that affects motor neurons. Learn about the causes and risk factors of ALS.